Open the filing on EDGARNASDAQ: CCLD
CareCloud Delivers Most Profitable Quarter in Company History: Record GAAP Net Income, Record GAAP EPS and Record adjusted EBITDA
SOMERSET, N.J., November 5, 2026 (GLOBE NEWSWIRE) - CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, today announced record financial results for the quarter ended September 30, 2026. CareCloud delivered the highest quarterly profitability in its history: record GAAP net income of $4.7 million, up 54% year over year from $3.1 million; record GAAP EPS of $0.10, up 150% from $0.04; and record adjusted EBITDA of $9.9 million, up 28% from $7.7 million in the third quarter of 2025.
Third Quarter 2026 Highlights
- Revenue of $33.7 million, compared to $31.1 million in Q3 2025, an increase of 9% year over year
- Record GAAP net income of $4.7 million, compared to $3.1 million in Q3 2025, an increase of 54% year over year
- Record net income attributable to common shareholders of $4.2 million, compared to $1.7 million in Q3 2025, an increase of 147% year over year
- Record GAAP EPS of $0.10 per share, compared to $0.04 per share in Q3 2025, an increase of 150% year over year
- Record adjusted EBITDA of $9.9 million, compared to $7.7 million in Q3 2025, an increase of 28% year over year
Year-to-date 2026 Highlights
- Revenue of $96.9 million, compared to $86.1 million in the same period last year, an increase of 13%
- GAAP net income of $6.8 million, compared to $7.9 million in the same period last year
- Net income attributable to common shareholders of $3.9 million, compared to $2.4 million in the same period last year
- GAAP EPS of $0.09 per share, compared to GAAP EPS of $0.07 per share in the same period last year
- Adjusted EBITDA of $21.2 million, compared to $19.9 million in the same period last year
Recent Accomplishments
- Record Quarterly Profitability. Q3 set all-time quarterly records across several key profitability measures including: GAAP net income of $4.7 million, GAAP EPS of $0.10 and adjusted EBITDA of $9.9 million (a 29% margin), up 54%, 150% and 28% year over year, respectively. Q3 GAAP EPS alone matched CareCloud’s GAAP EPS for all of 2025. Q3 was the Company’s 10th consecutive quarter of positive GAAP net income.
- Reduced debt by $7.4 million, including a $0.8 million prepayment. On May 15, 2026, CareCloud redeemed all of its Series B Preferred Stock for $41.6 million with proceeds from its credit facility, replacing perpetual preferred stock with lower-cost debt that amortizes monthly. As of November 2, the term loan stands at $34.2 million. Additionally, the $9 million borrowed on the line of credit was repaid. The Company intends to make additional prepayments on the term loan as cash flow permits.
- AI and Automation driving efficiency. CareCloud has built AI into its claims processing. Over the past three months, it cut manual claim touches by 44% in the division that serves the majority of its RCM clients, allowing teams to handle more volume without adding headcount.
- Compliance as a cross-sell engine. Empower, acquired in May 2026, recently reversed more than $1 million in alleged payers overpayments for a client, and has already opened doors to new CareCloud RCM signings with an MSO and a wound care practice. On October 21, CareCloud appointed Empower founder Mitchell Brie, CHC, as Chief Compliance Officer to scale compliance services across its more than 40,000 providers, and plans to launch a SaaS compliance offering in late Q4 2026.
Management Commentary
“Record GAAP net income, record GAAP EPS and record adjusted EBITDA: the third quarter was the most profitable in CareCloud’s history, and the $0.10 we earned per share in a single quarter matched what we earned in all of 2025. With ten consecutive profitable quarters behind us, we are putting those earnings to work, paying down debt every month while investing in the AI-enabled solutions, compliance platform and cross-selling opportunity across the customer base that will drive our next phase of growth. That momentum is why we are reaffirming our full-year guidance.”
- Stephen Snyder, Chief Executive Officer, CareCloud
“LailaCare shows what our AI strategy looks like in practice: we are building AI-enabled workflows for enterprise clients, and we recognized our first revenue from that work this quarter. Inside our own operations, AI and automation have cut manual claim touches by 44% in just three months, so our teams handle more volume with the same headcount, and that efficiency helped power this quarter’s record adjusted EBITDA. Our focus now is converting those capabilities into cross-sell revenue across our client base.”
- A. Hadi Chaudhry, Chief Strategy Officer, CareCloud
“Record earnings and a simpler capital structure are working together for common shareholders. Net income attributable to common shareholders more than doubled to $4.2 million year over year, and the cash our business produces is steadily reducing our debt, so more of CareCloud’s value belongs to our shareholders every quarter.”
- Bonnie Boyer, Chief Financial Officer, CareCloud
2026 Outlook: Priorities remain clear
Third quarter adjusted EBITDA grew 28% year over year to a record $9.9 million, alongside record GAAP net income and GAAP EPS. Third quarter revenue less direct operating costs rose to 50.5% of revenue from 47.8%, driven by a shift toward higher-margin offerings and a more efficient core business. We are investing in organic growth through AI-enabled technology and process transformation for enterprise clients, our planned late-Q4 SaaS compliance launch, and cross-selling across more than 40,000 providers, while using free cash flow to reduce debt.
The Company is reaffirming its guidance for calendar year 2026.
| For the Fiscal Year Ending December 31, 2026 | Full Year 2026 Guidance |
| Revenue | $128 - $132 million |
| Adjusted EBITDA | $29 - $31 million |
| GAAP Net Income Per Share (EPS) | $0.20 - $0.23 |
Revenue guidance is based on management’s expectations for contributions from existing clients, together with cross-selling and other organic and inorganic growth. GAAP EPS guidance of $0.20 - $0.23 represents a 100-130% increase from the $0.10 achieved in full year 2025. Adjusted EBITDA guidance of $29 - $31 million represents growth of approximately 5 - 13% over 2025 actuals of $27.5 million. The Company’s ability to achieve guidance is contingent, among other things, on the continued performance of its existing and new customers, and an impairment to the relationship of one or more of these customers could have a material adverse effect on the Company’s performance.
Conference Call Information
CareCloud management will host a live conference call today, November 5, 2026, at 8:30 a.m. Eastern Time to discuss third quarter 2026 results and the Company’s 2026 strategy.
Webcast: ir.carecloud.com/events
Dial-in (Audio Only): 201-389-0920 | Reference: “CareCloud, Inc. Third Quarter 2026 Results Conference Call.”
Replay Dial-in: 412-317-6671 | Access Code: 13762600 (available approximately 3 hours after the call).
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.
Use of Non-GAAP Financial Measures
In our earnings releases, prepared remarks, conference calls, slide presentations and webcasts, we use and discuss non-GAAP financial measures, as defined by SEC Regulation G. The GAAP financial measure most directly comparable to each non-GAAP financial measure used or discussed and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included in this press release after the condensed consolidated financial statements. Our earnings press releases containing such non-GAAP reconciliations can be found in the Investor Relations section of our web site at ir.carecloud.com.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities and the expected results from the integration of our acquisitions.
Forward-looking statements notice
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, manage and keep our information systems secure and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF SEPTEMBER 30, 2026 AND DECEMBER 31, 2025
($ in thousands, except share and per share amounts)
| September 30, | December 31, |
|---|
| 2026 | 2025 |
|---|
| (Unaudited) | |
|---|
| ASSETS | | |
| Current assets: | | |
| Cash | $4,636 | $3,117 |
| Restricted cash | - | 500 |
| Accounts receivable - net | 16,529 | 15,062 |
| Contract asset | 3,063 | 3,664 |
| Inventory | 512 | 507 |
| Current assets - related party | 16 | 16 |
| Prepaid expenses and other current assets | 3,636 | 2,872 |
| Total current assets | 28,392 | 25,738 |
| Property and equipment - net | 6,836 | 7,775 |
| Operating lease right-of-use assets | 5,245 | 3,106 |
| Intangible assets - net | 14,261 | 18,968 |
| Goodwill | 31,631 | 31,442 |
| Other assets | 734 | 569 |
| TOTAL ASSETS | $87,099 | $87,598 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | | |
| Current liabilities: | | |
| Accounts payable | $6,204 | $6,937 |
| Accrued compensation | 3,859 | 4,136 |
| Accrued expenses | 5,703 | 5,970 |
| Operating lease liability | 1,677 | 927 |
| Deferred revenue | 3,944 | 4,148 |
| Term and other loans | 10,597 | 728 |
| Contingent consideration | 256 | 909 |
| Dividend payable | 392 | 668 |
| Total current liabilities | 32,632 | 24,423 |
| Term and other loans | 26,698 | 441 |
| Contingent consideration | 192 | 232 |
| Operating lease liability | 3,835 | 2,187 |
| Deferred revenue | 1,023 | 809 |
| Deferred tax liability | 95 | - |
| Total liabilities | 64,475 | 28,092 |
| COMMITMENTS AND CONTINGENCIES | | |
| SHAREHOLDERS’ EQUITY: | | |
| Preferred stock, $0.001 par value - authorized 7,000,000 shares. Series A, issued and outstanding 984,530 shares at September 30, 2026 and December 31, 2025. Series B, issued and outstanding 0 and 1,511,372 shares at September 30, 2026 and December 31, 2025, respectively. | 1 | 2 |
| Common stock, $0.001 par value - authorized 85,000,000 shares. Issued 43,289,658 and 43,178,748 shares at September 30, 2026 and December 31, 2025, respectively. Outstanding 42,548,859 and 42,437,949 shares at September 30, 2026 and December 31, 2025, respectively. | 43 | 43 |
| Additional paid-in capital | 76,196 | 119,936 |
| Accumulated deficit | (49,061) | (55,832) |
| Accumulated other comprehensive loss | (3,893) | (3,981) |
| Less: 740,799 common shares held in treasury, at cost at September 30, 2026 and December 31, 2025 | (662) | (662) |
| Total shareholders’ equity | 22,624 | 59,506 |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $87,099 | $87,598 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
($ in thousands, except share and per share amounts)
| Three Months Ended | Nine Months Ended |
|---|
| September 30, | September 30, |
|---|
| 2026 | 2025 | 2026 | 2025 |
|---|
| NET REVENUE | $33,725 | $31,067 | $96,875 | $86,076 |
| OPERATING EXPENSES: | | | | |
| Direct operating costs | 16,709 | 16,224 | 51,016 | 46,168 |
| Selling and marketing | 1,305 | 1,123 | 4,019 | 3,372 |
| General and administrative | 4,951 | 4,887 | 15,817 | 13,577 |
| Research and development | 1,052 | 1,584 | 5,662 | 3,839 |
| Change in contingent consideration | (32) | - | (9) | - |
| Depreciation and amortization | 3,165 | 4,022 | 10,933 | 10,741 |
| Restructuring costs | - | 17 | - | 154 |
| Total operating expenses | 27,150 | 27,857 | 87,438 | 77,851 |
| OPERATING INCOME | 6,575 | 3,210 | 9,437 | 8,225 |
| OTHER: | | | | |
| Interest income | 81 | 95 | 164 | 188 |
| Interest expense | (1,801) | (147) | (2,674) | (273) |
| Other (expense) income - net | (1) | (55) | 125 | (104) |
| INCOME BEFORE PROVISION FOR INCOME TAXES | 4,854 | 3,103 | 7,052 | 8,036 |
| Income tax provision | 127 | 43 | 281 | 126 |
| NET INCOME | $4,727 | $3,060 | $6,771 | $7,910 |
| Preferred stock dividend | 538 | 1,365 | 2,844 | 5,541 |
| NET INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS | $4,189 | $1,695 | $3,927 | $2,369 |
| Net income per common share: basic and diluted | $0.10 | $0.04 | $0.09 | $0.07 |
| Weighted-average common shares used to compute basic and diluted income per share | 42,528,315 | 42,368,914 | 42,498,112 | 36,236,128 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
($ in thousands)
| 2026 | 2025 |
|---|
| OPERATING ACTIVITIES: | | |
| Net income | $6,771 | $7,910 |
| Adjustments to reconcile net income to net cash provided by operating activities: | | |
| Depreciation and amortization | 11,083 | 10,936 |
| Lease amortization | 1,317 | 1,319 |
| Provision for expected credit losses | 409 | 343 |
| Provision for deferred income taxes | 95 | - |
| Foreign exchange loss | 13 | 60 |
| Interest accretion | 1,254 | 326 |
| Change in contingent consideration | (9) | - |
| Stock-based compensation expense | 193 | 307 |
| Changes in operating assets and liabilities: | | |
| Accounts receivable | (1,876) | (796) |
| Contract asset | 601 | 461 |
| Inventory | (5) | (31) |
| Other assets | (812) | (2,581) |
| Accounts payable and other liabilities | (2,684) | 2,124 |
| Deferred revenue | (23) | (492) |
| Net cash provided by operating activities | 16,327 | 19,886 |
| INVESTING ACTIVITIES: | | |
| Purchases of property and equipment | (1,265) | (2,655) |
| Capitalized software and other intangible assets | (3,146) | (2,505) |
| Payments for acquisitions | (967) | (16,040) |
| Net cash used in investing activities | (5,378) | (21,200) |
| FINANCING ACTIVITIES: | | |
| Preferred stock dividends paid | (6,974) | (4,821) |
| Payment of contingent consideration | (677) | (53) |
| Payment of tax withholding on stock issued to employees | (2) | (22) |
| Proceeds from term loan | 39,756 | - |
| Repayments of term and other loans | (3,874) | (378) |
| Redemption of Series B Preferred Stock | (38,169) | - |
| Proceeds from line of credit | 9,000 | 8,343 |
| Repayments of line of credit | (9,000) | (1,843) |
| Net cash (used in) provided by financing activities | (9,940) | 1,226 |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH AND RESTRICTED CASH | 10 | 16 |
| NET INCREASE (DECREASE) IN CASH AND RESTRICTED CASH | 1,019 | (72) |
| CASH AND RESTRICTED CASH - Beginning of the period | 3,617 | 5,145 |
| CASH AND RESTRICTED CASH - End of the period | $4,636 | $5,073 |
| SUPPLEMENTAL NONCASH INVESTING AND FINANCING ACTIVITIES: | | |
| Conversion of preferred stock and accrued dividends to common stock | $- | $2,435 |
| Dividends declared, not paid | $392 | $714 |
| SUPPLEMENTAL INFORMATION - Cash paid during the period for: | | |
| Income taxes | $171 | $172 |
| Interest | $1,376 | $64 |
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
TO COMPARABLE GAAP MEASURES (UNAUDITED)
The following is a reconciliation of the non-GAAP financial measures used by us to describe our financial results determined in accordance with accounting principles generally accepted in the United States of America (“GAAP”). An explanation of these measures is also included below under the heading “Explanation of Non-GAAP Financial Measures.”
While management believes that these non-GAAP financial measures provide useful supplemental information to investors regarding the underlying performance of our business operations, investors are reminded to consider these non-GAAP measures in addition to, and not as a substitute for, financial performance measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies, and management may utilize other measures to illustrate performance in the future. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP.
Adjusted EBITDA to GAAP Net Income
Set forth below is a reconciliation of our “adjusted EBITDA” to our GAAP net income.
| Three Months Ended September 30, | Nine Months Ended September 30, |
|---|
| 2026 | 2025 | 2026 | 2025 |
|---|
| ($ in thousands) |
|---|
| Net revenue | $33,725 | $31,067 | $96,875 | $86,076 |
| GAAP net income | 4,727 | 3,060 | 6,771 | 7,910 |
| Provision for income taxes | 127 | 43 | 281 | 126 |
| Net interest expense | 1,720 | 52 | 2,510 | 85 |
| Foreign exchange loss / other expense | 7 | 60 | 93 | 120 |
| Stock-based compensation expense | 65 | 88 | 193 | 307 |
| Depreciation and amortization | 3,189 | 4,022 | 10,957 | 10,741 |
| Change in contingent consideration | (32) | - | (9) | - |
| Transaction and integration costs | 77 | 391 | 401 | 414 |
| Restructuring costs | - | 17 | - | 154 |
| Adjusted EBITDA | $9,880 | $7,733 | $21,197 | $19,857 |
Non-GAAP Adjusted Operating Income to GAAP Operating Income
Set forth below is a reconciliation of our non-GAAP “adjusted operating income” and non-GAAP “adjusted operating margin” to our GAAP operating income and GAAP operating margin.
| Three Months Ended September 30, | Nine Months Ended September 30, |
|---|
| 2026 | 2025 | 2026 | 2025 |
|---|
| ($ in thousands) |
|---|
| Net revenue | $33,725 | $31,067 | $96,875 | $86,076 |
| GAAP net income | 4,727 | 3,060 | 6,771 | 7,910 |
| Provision for income taxes | 127 | 43 | 281 | 126 |
| Net interest expense | 1,720 | 52 | 2,510 | 85 |
| Other expense (income) - net | 1 | 55 | (125) | 104 |
| GAAP operating income | 6,575 | 3,210 | 9,437 | 8,225 |
| GAAP operating margin | 19.5% | 10.3% | 9.7% | 9.6% |
| Stock-based compensation expense | 65 | 88 | 193 | 307 |
| Amortization of purchased intangible assets | 939 | 794 | 2,812 | 1,076 |
| Transaction and integration costs | 77 | 391 | 401 | 414 |
| Change in contingent consideration | (32) | - | (9) | - |
| Restructuring costs | - | 17 | - | 154 |
| Non-GAAP adjusted operating income | $7,624 | $4,500 | $12,834 | $10,176 |
| Non-GAAP adjusted operating margin | 22.6% | 14.5% | 13.2% | 11.8% |
Non-GAAP Adjusted Net Income to GAAP Net Income
Set forth below is a reconciliation of our non-GAAP “adjusted net income” and non-GAAP “adjusted net income per share” to our GAAP net income and GAAP net income per share.
| Three Months Ended September 30, | Nine Months Ended September 30, |
|---|
| 2026 | 2025 | 2026 | 2025 |
|---|
| ($ in thousands ) |
|---|
| GAAP net income | $4,727 | $3,060 | $6,771 | $7,910 |
| Foreign exchange loss / other expense | 7 | 60 | 93 | 120 |
| Stock-based compensation expense | 65 | 88 | 193 | 307 |
| Amortization of purchased intangible assets | 939 | 794 | 2,812 | 1,076 |
| Transaction and integration costs | 77 | 391 | 401 | 414 |
| Change in contingent consideration | (32) | - | (9) | - |
| Restructuring costs | - | 17 | - | 154 |
| Income tax expense related to goodwill | 45 | - | 95 | - |
| Non-GAAP adjusted net income | $5,828 | $4,410 | $10,356 | $9,981 |
| Three Months Ended September 30, | Nine Months Ended September 30, |
|---|
| 2026 | 2025 | 2026 | 2025 |
|---|
| GAAP net income attributable to common shareholders, per share | $0.10 | $0.04 | $0.09 | $0.07 |
| Impact of preferred stock dividend | 0.01 | 0.03 | 0.07 | 0.12 |
| Net income per end-of-period share | 0.11 | 0.07 | 0.16 | 0.19 |
| Foreign exchange loss / other expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-based compensation expense | 0.00 | 0.00 | 0.00 | 0.01 |
| Amortization of purchased intangible assets | 0.03 | 0.02 | 0.07 | 0.03 |
| Transaction and integration costs | 0.00 | 0.01 | 0.01 | 0.01 |
| Change in contingent consideration | 0.00 | - | 0.00 | - |
| Restructuring costs | - | 0.00 | - | 0.00 |
| Income tax expense related to goodwill | 0.00 | - | 0.00 | 0.00 |
| Non-GAAP adjusted earnings per share | $0.14 | $0.10 | $0.24 | $0.24 |
| End-of-period common shares | 42,548,859 | 42,397,039 | 42,548,859 | 42,397,039 |
For purposes of determining non-GAAP adjusted earnings per share, the Company used the number of common shares outstanding as of September 30, 2026 and 2025. Non-GAAP adjusted earnings per share does not take into account dividends declared or earned on preferred stock.
Net cash provided by operating activities to free cash flow
Set forth below is a reconciliation of our non-GAAP “free cash flow” to our GAAP net cash provided by operating activities.
| Three Months Ended September 30, | Nine Months Ended September 30, |
|---|
| 2026 | 2025 | 2026 | 2025 |
|---|
| ($ in thousands) |
|---|
| Net cash provided by operating activities | $5,643 | $7,365 | $16,327 | $19,886 |
| Purchases of property and equipment | (328) | (869) | (1,265) | (2,655) |
| Capitalized software and other intangible assets | (1,526) | (828) | (3,146) | (2,505) |
| Free cash flow | $3,789 | $5,668 | $11,916 | $14,726 |
| Net cash used in investing activities | $(2,140) | $(17,697) | $(5,378) | $(21,200) |
| Net cash (used in) provided by financing activities | $(12,264) | $4,920 | $(9,940) | $1,226 |
1. Net cash in investing includes payments for acquisitions, purchases of property and equipment and capitalized software and other intangible assets. Purchases of property and equipment and capitalized software and other intangible assets are included in our computation of free cash flow.
Explanation of Non-GAAP Financial Measures
We report our financial results in accordance with accounting principles generally accepted in the United States of America, or GAAP. However, management believes that, in order to properly understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures in accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management also uses results of operations before such items to evaluate the operating performance of CareCloud and compare it against past periods, make operating decisions and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts. Management believes that these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.
Management uses adjusted EBITDA, adjusted operating income, adjusted operating margin, and non-GAAP adjusted net income to provide an understanding of aspects of operating results before the impact of investing and financing charges and income taxes. Adjusted EBITDA may be useful to an investor in evaluating our operating performance and liquidity because this measure excludes non-cash expenses as well as expenses pertaining to investing or financing transactions. Management defines “adjusted EBITDA” as the sum of GAAP net income (loss) before provision for (benefit from) income taxes, net interest expense, other (income) expense, stock-based compensation expense, depreciation and amortization, integration costs, transaction costs, impairment charges, restructuring costs and changes in contingent consideration.
Management defines “non-GAAP adjusted operating income” as the sum of GAAP operating income (loss) before stock-based compensation expense, amortization of purchased intangible assets, integration costs, transaction costs, impairment charges, restructuring costs and changes in contingent consideration, and “non-GAAP adjusted operating margin” as non-GAAP adjusted operating income divided by net revenue.
Management defines “non-GAAP adjusted net income” as the sum of GAAP net income (loss) before stock-based compensation expense, amortization of purchased intangible assets, other (income) expense, integration costs, transaction costs, impairment charges, restructuring costs, changes in contingent consideration, any tax impact related to these preceding items and income tax expense related to goodwill, and “non-GAAP adjusted net income per share” as non-GAAP adjusted net income divided by common shares outstanding at the end of the period, including the shares which were issued but are subject to forfeiture and considered contingent consideration.
Management considers all of these non-GAAP financial measures to be important indicators of our operational strength and performance of our business and a good measure of our historical operating trends, in particular the extent to which ongoing operations impact our overall financial performance.
In addition to items routinely excluded from non-GAAP EBITDA, management excludes or adjusts each of the items identified below from the applicable non-GAAP financial measure referenced above for the reasons set forth with respect to that excluded item:
Foreign exchange loss/other expense. Other expense is excluded because foreign currency gains and losses and other non-operating expenses are expenditures that management does not consider part of ongoing operating results when assessing the performance of our business, and also because the total amount of the expense is partially outside of our control. Foreign currency gains and losses are based on global market factors which are unrelated to our performance during the period in which the gains and losses are recorded.
Stock-based compensation expense. Stock-based compensation expense is excluded because this is primarily a non-cash expenditure that management does not consider part of ongoing operating results when assessing the performance of our business, and also because the total amount of the expenditure is partially outside of our control because it is based on factors such as stock price, volatility, and interest rates, which may be unrelated to our performance during the period in which the expenses are incurred. Stock-based compensation expense includes cash-settled awards based on changes in the stock price.
Amortization of purchased intangible assets. Purchased intangible assets are amortized over their estimated useful lives and generally cannot be changed or influenced by management after the acquisition. Accordingly, this item is not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are recorded.
Transaction costs. Transaction costs are upfront costs related to acquisitions and related transactions, such as brokerage fees, pre-acquisition accounting costs and legal fees, and other upfront costs related to specific transactions. Management believes that such expenses do not have a direct correlation to future business operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
Integration costs. Integration costs are severance payments for certain employees relating to our acquisitions and exit costs related to terminating leases and other contractual agreements. Accordingly, management believes that such expenses do not have a direct correlation to future business operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
Contingent consideration. Contingent consideration represents the portion of consideration payable to the seller of some of our acquisitions, the amount of which is based on the achievement defined performance measures contained in the purchase agreements. Contingent consideration is adjusted to fair value at the end of each reporting period. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
Restructuring costs. Restructuring costs primarily consist of severance and separation costs associated with the optimization of the Company’s operations and profitability improvements. Management believes that such expenses do not have a direct correlation to future business operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
Income tax expense related to goodwill. Income tax expense resulting from the amortization of goodwill related to our acquisitions represents a charge to record the tax effect resulting from amortizing goodwill over 15 years for tax purposes. Goodwill is not amortized for GAAP reporting. This expense is not anticipated to result in a cash payment.
Free cash flow. Management believes that free cash flow, which measures our ability to generate additional cash from our business operations, is an important financial measure for use in evaluating the Company’s financial performance. Free cash flow should be considered in addition to, rather than as a substitute for, consolidated net operating results as a measure of our performance and net cash provided by operating activities as a measure of our liquidity. Additionally, the Company’s definition of free cash flow is limited, in that it does not represent residual cash flows available for discretionary expenditures, due to the fact that the measure does not deduct the payments required for debt service and other contractual obligations or payments made for business acquisitions. Therefore, we believe it is important to view free cash flow as a measure that provides supplemental information to our condensed consolidated statements of cash flows.
Contacts
Company Contact: Bonnie Boyer · Chief Financial Officer · CareCloud, Inc. · bboyer@carecloud.com
Stephen Snyder · Chief Executive Officer · CareCloud, Inc. · ir@carecloud.com